Patents Assigned to Sinexus, Inc.
-
Patent number: 7686798Abstract: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.Type: GrantFiled: April 7, 2009Date of Patent: March 30, 2010Assignee: Sinexus, Inc.Inventors: Donald J. Eaton, Mary L. Moran, Rodney Brenneman
-
Patent number: 7662141Abstract: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.Type: GrantFiled: April 7, 2009Date of Patent: February 16, 2010Assignee: Sinexus, Inc.Inventors: Donald J. Eaton, Mary L. Moran, Rodney Brenneman
-
Patent number: 7662142Abstract: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.Type: GrantFiled: April 7, 2009Date of Patent: February 16, 2010Assignee: Sinexus, Inc.Inventors: Donald J. Eaton, Mary L. Moran, Rodney Brenneman
-
Publication number: 20090306624Abstract: Described here are devices, methods, and kits for treating sinusitis and related respiratory conditions by locally delivering active agents to the osteomeatal complex over a sustained period of time. The devices may be passively fixed within the osteomeatal complex and/or include one or more features that actively fix it within the osteomeatal complex. The devices may optionally include a portion that extends into a sinus ostium, sinus cavity, and/or the nasal passage to deliver an active agent.Type: ApplicationFiled: August 14, 2009Publication date: December 10, 2009Applicant: Sinexus, Inc.Inventors: Patrick A. ARENSDORF, Danielle L. Biggs, Rodney Brenneman, David B. Downie, Donald J. Eaton, Thomas R. Tice
-
Publication number: 20090238859Abstract: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.Type: ApplicationFiled: June 6, 2009Publication date: September 24, 2009Applicant: Sinexus, Inc.Inventors: Donald J. EATON, Mary Lynn Moran, Rodney A. Brenneman
-
Publication number: 20090156980Abstract: Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus condition. Exemplary paranasal sinus conditions are sinus inflammation due to functional endoscopic sinus surgery (FESS) and rhinosinusitis.Type: ApplicationFiled: November 13, 2008Publication date: June 18, 2009Applicant: Sinexus, Inc.Inventors: Donald J. EATON, Thomas R. Tice, David B. Downie, Patrick A. Arensdorf, Rodney Brenneman, Danielle L. Biggs
-
Patent number: 7547323Abstract: A stent comprises a flexible tube having a proximal end, a distal end, and a passageway extending from said proximal end toward said distal end. A first generally straight tube segment extends from the proximal end while a first generally curved segment extends from an end region of the first generally straight tube segment disposed away from the proximal end of the stent. A second generally straight tube segment extends from an end region of the first curved segment away from the first generally straight tube segment and is arranged at an acute angle relative to the first generally straight tube segment. A second generally curved tube segment extends from one end of the second generally straight tube segment and includes a channel on an exterior surface of the second generally curved tube segment.Type: GrantFiled: August 29, 2006Date of Patent: June 16, 2009Assignee: Sinexus, Inc.Inventor: François Lavigne
-
Patent number: 7544192Abstract: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.Type: GrantFiled: March 12, 2004Date of Patent: June 9, 2009Assignee: Sinexus, Inc.Inventors: Donald J. Eaton, Mary L. Moran, Rodney Brenneman